Aurora Cannabis | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aurora Cannabis | 6-K: Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors
Aurora Cannabis | 6-K: Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Future Cultivation Excellence
Aurora Cannabis | 6-K: Material Change Report
Aurora Cannabis | 6-K: Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting
Aurora Cannabis | 6-K: Aurora Cannabis and Vectura Fertin Pharma, Inc. announce commercial collaboration
Aurora Cannabis | 6-K: Aurora Receives Expanded Cultivation and Unique Research Licenses for German Facility
Aurora Cannabis | 6-K: Aurora Receives Expanded Cultivation and Unique Research Licenses for German Facility
Aurora Cannabis | 6-K: Aurora Cannabis Inc. Announces Filing and Mailing of Management Information Circular in Connection with Upcoming Annual General and Special Meeting of Shareholders
Aurora Cannabis | 6-K: Notice of Meeting and Record Date
Aurora Cannabis | 6-K: Aurora Cannabis Announces Appointment of New Director
Aurora Cannabis | 6-K: Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market
Aurora Cannabis | 6-K: Notice of Change of Auditor
Aurora Cannabis | 6-K: Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free
Aurora Cannabis | 6-K: Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation
Aurora Cannabis | 6-K: Material Change Report
Aurora Cannabis | 6-K: Aurora Cannabis Acquires MedReleaf Australia
Aurora Cannabis | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aurora Cannabis | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aurora Cannabis | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
No Data
No Data